{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:46:56Z","timestamp":1794192416288,"version":"4.8.0"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"DOI":"10.1186\/s12977-026-00678-5","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:54:41Z","timestamp":1780692881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-integrase mechanisms for dolutegravir resistance"],"prefix":"10.1186","volume":"23","author":[{"given":"Alan N.","family":"Engelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"678_CR1","doi-asserted-by":"publisher","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","volume":"2","author":"WI Sundquist","year":"2012","unstructured":"Sundquist WI, Kr\u00e4usslich HG. HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med. 2012;2:a006924.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"678_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","volume":"33","author":"E De Clercq","year":"2009","unstructured":"De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents. 2009;33:307\u201320.","journal-title":"Int J Antimicrob Agents"},{"key":"678_CR3","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(18)30710-2","volume":"19","author":"SC Inzaule","year":"2019","unstructured":"Inzaule SC, Hamers RL, Doherty M, Shafer RW, Bertagnolio S, Rinke de Wit TF. Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens. Lancet Infect Dis. 2019;19:e246\u201352.","journal-title":"Lancet Infect Dis"},{"key":"678_CR4","doi-asserted-by":"publisher","first-page":"a006882","DOI":"10.1101\/cshperspect.a006882","volume":"2","author":"WS Hu","year":"2012","unstructured":"Hu WS, Hughes SH. HIV-1 reverse transcription. Cold Spring Harb Perspect Med. 2012;2:a006882.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"678_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","volume":"385","author":"SG Sarafianos","year":"2009","unstructured":"Sarafianos SG, Marchand B, Das K, Himmel DM, Parniak MA, Hughes SH, Arnold E. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol. 2009;385:693\u2013713.","journal-title":"J Mol Biol"},{"key":"678_CR6","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1128\/jvi.67.6.3246-3253.1993","volume":"67","author":"M Jiang","year":"1993","unstructured":"Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, Kleiman L. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol. 1993;67:3246\u201353.","journal-title":"J Virol"},{"key":"678_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0092-8674(85)90303-4","volume":"40","author":"S Wain-Hobson","year":"1985","unstructured":"Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 1985;40:9\u201317.","journal-title":"Cell"},{"key":"678_CR8","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1002\/j.1460-2075.1989.tb08488.x","volume":"8","author":"C Barat","year":"1989","unstructured":"Barat C, Lullien V, Schatz O, Keith G, Nugeyre MT, Gr\u00fcninger-Leitch F, Barr\u00e9-Sinoussi F, LeGrice SF, Darlix JL. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 1989;8:3279\u201385.","journal-title":"EMBO J"},{"key":"678_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.2457948","volume":"241","author":"AT Panganiban","year":"1988","unstructured":"Panganiban AT, Fiore D. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science. 1988;241:1064\u20139.","journal-title":"Science"},{"key":"678_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/viro.1998.9096","volume":"244","author":"JL van Wamel","year":"1998","unstructured":"van Wamel JL, Berkhout B. The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology. 1998;244:245\u201351.","journal-title":"Virology"},{"key":"678_CR11","doi-asserted-by":"publisher","first-page":"28384","DOI":"10.1074\/jbc.273.43.28384","volume":"273","author":"H Yu","year":"1998","unstructured":"Yu H, Jetzt AE, Ron Y, Preston BD, Dougherty JP. The nature of human immunodeficiency virus type 1 strand transfers. J Biol Chem. 1998;273:28384\u201391.","journal-title":"J Biol Chem"},{"key":"678_CR12","doi-asserted-by":"publisher","first-page":"10565","DOI":"10.1016\/S0021-9258(18)86984-8","volume":"265","author":"HE Huber","year":"1990","unstructured":"Huber HE, Richardson CC. Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase. J Biol Chem. 1990;265:10565\u201373.","journal-title":"J Biol Chem"},{"key":"678_CR13","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1128\/jvi.66.5.2814-2820.1992","volume":"66","author":"P Charneau","year":"1992","unstructured":"Charneau P, Alizon M, Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol. 1992;66:2814\u201320.","journal-title":"J Virol"},{"key":"678_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41586-018-0750-6","volume":"564","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wang GZ, Cing\u00f6z O, Goff SP. NP220 mediates silencing of unintegrated retroviral DNA. Nature. 2018;564:278\u201382.","journal-title":"Nature"},{"key":"678_CR15","doi-asserted-by":"publisher","first-page":"23735","DOI":"10.1073\/pnas.1912638116","volume":"116","author":"FK Geis","year":"2019","unstructured":"Geis FK, Goff SP. Unintegrated HIV-1 DNAs are loaded with core and linker histones and transcriptionally silenced. Proc Natl Acad Sci USA. 2019;116:23735\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"678_CR16","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1073\/pnas.1913754117","volume":"117","author":"S Machida","year":"2020","unstructured":"Machida S, Depierre D, Chen HC, Thenin-Houssier S, Petitjean G, Doyen CM, Takaku M, Cuvier O, Benkirane M. Exploring histone loading on HIV DNA reveals a dynamic nucleosome positioning between unintegrated and integrated viral genome. Proc Natl Acad Sci USA. 2020;117:6822\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"678_CR17","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/v13112248","volume":"13","author":"SP Goff","year":"2021","unstructured":"Goff SP. Silencing of unintegrated retroviral DNAs. Viruses. 2021;13:2248.","journal-title":"Viruses"},{"key":"678_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.chom.2021.03.001","volume":"29","author":"L Dupont","year":"2021","unstructured":"Dupont L, Bloor S, Williamson JC, Cuesta SM, Shah R, Teixeira-Silva A, Naamati A, Greenwood EJD, Sarafianos SG, Matheson NJ, Lehner PJ. The SMC5\/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr. Cell Host Microbe. 2021;29:792\u2013805.e6.","journal-title":"Cell Host Microbe"},{"key":"678_CR19","doi-asserted-by":"publisher","first-page":"e1011180","DOI":"10.1371\/journal.ppat.1011180","volume":"19","author":"ID Irwan","year":"2023","unstructured":"Irwan ID, Cullen BR. The SMC5\/6 complex: An emerging antiviral restriction factor that can silence episomal DNA. PLoS Pathog. 2023;19:e1011180.","journal-title":"PLoS Pathog"},{"key":"678_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41579-020-0382-3","volume":"18","author":"K Tsai","year":"2020","unstructured":"Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication. Nat Rev Microbiol. 2020;18:559\u201370.","journal-title":"Nat Rev Microbiol"},{"key":"678_CR21","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1128\/JVI.77.7.3962-3972.2003","volume":"77","author":"B Poon","year":"2003","unstructured":"Poon B, Chen IS. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J Virol. 2003;77:3962\u201372.","journal-title":"J Virol"},{"key":"678_CR22","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1128\/JVI.00947-07","volume":"81","author":"B Poon","year":"2007","unstructured":"Poon B, Chang MA, Chen IS. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. J Virol. 2007;81:10515\u201323.","journal-title":"J Virol"},{"key":"678_CR23","doi-asserted-by":"publisher","first-page":"e01038","DOI":"10.1128\/mBio.01038-20","volume":"11","author":"ID Irwan","year":"2020","unstructured":"Irwan ID, Karnowski HL, Bogerd HP, Tsai K, Cullen BR. Reversal of epigenetic silencing allows robust HIV-1 replication in the absence of integrase function. mBio. 2020;11:e01038\u201320.","journal-title":"mBio"},{"key":"678_CR24","doi-asserted-by":"publisher","first-page":"e0028521","DOI":"10.1128\/JVI.00285-21","volume":"95","author":"ID Irwan","year":"2021","unstructured":"Irwan ID, Cullen BR. Tax induces the recruitment of NF-\u03baB to unintegrated HIV-1 DNA to rescue viral gene expression and replication. J Virol. 2021;95:e0028521.","journal-title":"J Virol"},{"key":"678_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41579-021-00586-9","volume":"20","author":"GN Maertens","year":"2022","unstructured":"Maertens GN, Engelman AN, Cherepanov P. Structure and function of retroviral integrase. Nat Rev Microbiol. 2022;20:20\u201334.","journal-title":"Nat Rev Microbiol"},{"key":"678_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/0042-6822(90)90161-J","volume":"179","author":"CD Pauza","year":"1990","unstructured":"Pauza CD. Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination. Virology. 1990;179:886\u20139.","journal-title":"Virology"},{"key":"678_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/0092-8674(91)90297-C","volume":"67","author":"A Engelman","year":"1991","unstructured":"Engelman A, Mizuuchi K, Craigie R. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell. 1991;67:1211\u201321.","journal-title":"Cell"},{"key":"678_CR28","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1093\/nar\/19.24.6691","volume":"19","author":"C Vink","year":"1991","unstructured":"Vink C, Yeheskiely E, van der Marel GA, van Boom JH, Plasterk RH. Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res. 1991;19:6691\u20138.","journal-title":"Nucleic Acids Res"},{"key":"678_CR29","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1128\/jvi.71.7.5382-5390.1997","volume":"71","author":"MD Miller","year":"1997","unstructured":"Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol. 1997;71:5382\u201390.","journal-title":"J Virol"},{"key":"678_CR30","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.2171144","volume":"249","author":"FD Bushman","year":"1990","unstructured":"Bushman FD, Fujiwara T, Craigie R. Retroviral DNA integration directed by HIV integration protein in vitro. Science. 1990;249:1555\u20138.","journal-title":"Science"},{"key":"678_CR31","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1073\/pnas.88.4.1339","volume":"88","author":"FD Bushman","year":"1991","unstructured":"Bushman FD, Craigie R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A. 1991;88:1339\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR32","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1128\/JVI.75.17.7944-7955.2001","volume":"75","author":"N Nakajima","year":"2001","unstructured":"Nakajima N, Lu R, Engelman A. Human immunodeficiency virus type 1 replication in the absence of integrase-mediated DNA recombination: Definition of permissive and nonpermissive T-cell lines. J Virol. 2001;75:7944\u201355.","journal-title":"J Virol"},{"key":"678_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/jvi.25.1.104-104.1978","volume":"25","author":"PR Shank","year":"1978","unstructured":"Shank PR, Varmus HE. Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus. J Virol. 1978;25:104\u201314.","journal-title":"J Virol"},{"key":"678_CR34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/0092-8674(78)90063-6","volume":"15","author":"PR Shank","year":"1978","unstructured":"Shank PR, Hughes SH, Kung HJ, Majors JE, Quintrell N, Guntaka RV, Bishop JM, Varmus HE. Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell. 1978;15:1383\u201395.","journal-title":"Cell"},{"key":"678_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/jvi.33.1.377-389.1980","volume":"33","author":"D Dina","year":"1980","unstructured":"Dina D, Benz EW Jr. Structure of murine sarcoma virus DNA replicative intermediates synthesized in vitro. J Virol. 1980;33:377\u201389.","journal-title":"J Virol"},{"key":"678_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1128\/jvi.43.2.544-554.1982","volume":"43","author":"RP Junghans","year":"1982","unstructured":"Junghans RP, Boone LR, Skalka AM. Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J Virol. 1982;43:544\u201354.","journal-title":"J Virol"},{"key":"678_CR37","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/emboj\/20.12.3272","volume":"20","author":"L Li","year":"2001","unstructured":"Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M, Martin SL, Bushman FD. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 2001;20:3272\u201381.","journal-title":"EMBO J"},{"key":"678_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0042-6822(03)00455-0","volume":"314","author":"JM Kilzer","year":"2003","unstructured":"Kilzer JM, Stracker T, Beitzel B, Meek K, Weitzman M, Bushman FD. Roles of host cell factors in circularization of retroviral DNA . Virology. 2003;314:460\u20137.","journal-title":"Virology"},{"key":"678_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1128\/jvi.40.1.164-172.1981","volume":"40","author":"C Shoemaker","year":"1981","unstructured":"Shoemaker C, Hoffman J, Goff SP, Baltimore D. Intramolecular integration within Moloney murine leukemia virus DNA. J Virol. 1981;40:164\u201372.","journal-title":"J Virol"},{"key":"678_CR40","doi-asserted-by":"publisher","first-page":"9823","DOI":"10.1073\/pnas.91.21.9823","volume":"91","author":"MS Lee","year":"1994","unstructured":"Lee MS, Craigie R. Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc Natl Acad Sci U S A. 1994;91:9823\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR41","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1073\/pnas.93.24.13659","volume":"93","author":"R Zheng","year":"1996","unstructured":"Zheng R, Jenkins TM, Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci U S A. 1996;93:13659\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nsb0797-567","volume":"4","author":"M Cai","year":"1997","unstructured":"Cai M, Zheng R, Caffrey M, Craigie R, Clore GM, Gronenborn AM. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol. 1997;4:567\u201377.","journal-title":"Nat Struct Biol"},{"key":"678_CR43","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1021\/bi00031a002","volume":"34","author":"PJ Lodi","year":"1995","unstructured":"Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, Gronenborn AM. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 1995;34:9826\u201333.","journal-title":"Biochemistry"},{"key":"678_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nsb0995-807","volume":"2","author":"AP Eijkelenboom","year":"1995","unstructured":"Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R, H\u00e5rd K. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat Struct Biol. 1995;2:807\u201310.","journal-title":"Nat Struct Biol"},{"key":"678_CR45","first-page":"2331","volume":"12","author":"J Kulkosky","year":"1992","unstructured":"Kulkosky J, Jones KS, Katz RA, Mack JP, Skalka AM. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral\/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol. 1992;12:2331\u20138.","journal-title":"Mol Cell Biol"},{"key":"678_CR46","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/jvi.66.11.6361-6369.1992","volume":"66","author":"A Engelman","year":"1992","unstructured":"Engelman A, Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol. 1992;66:6361\u20139.","journal-title":"J Virol"},{"key":"678_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1126\/science.7801124","volume":"266","author":"F Dyda","year":"1994","unstructured":"Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 1994;266:1981\u20136.","journal-title":"Science"},{"key":"678_CR48","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/emboj.2012.118","volume":"31","author":"S Hare","year":"2012","unstructured":"Hare S, Maertens GN, Cherepanov P. 3\u2019-processing and strand transfer catalysed by retroviral integrase in crystallo. EMBO J. 2012;31:3020\u20138.","journal-title":"EMBO J"},{"key":"678_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0065-3527(08)60309-7","volume":"52","author":"A Engelman","year":"1999","unstructured":"Engelman A. In vivo analysis of retroviral integrase structure and function. Adv Virus Res. 1999;52:411\u201326.","journal-title":"Adv Virus Res"},{"key":"678_CR50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2016.07.044","volume":"166","author":"JJ Kessl","year":"2016","unstructured":"Kessl JJ, Kutluay SB, Townsend D, Rebensburg S, Slaughter A, Larue RC, Shkriabai N, Bakouche N, Fuchs JR, Bieniasz PD, Kvaratskhelia M. HIV-1 integrase binds the viral RNA genome and is essential during virion morphogenesis. Cell. 2016;166:1257\u201368.e12.","journal-title":"Cell"},{"key":"678_CR51","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41586-026-10154-x","volume":"652","author":"MR Singer","year":"2026","unstructured":"Singer MR, Li Z, Rey JS, Hope J, Chenavier F, Cook NJ, Punch E, Smith J, Zhou Z, Maslen S, et al. Integrase anchors viral RNA to the HIV-1 capsid interior. Nature. 2026;652:1068\u201375.","journal-title":"Nature"},{"key":"678_CR52","doi-asserted-by":"publisher","first-page":"e54311","DOI":"10.7554\/eLife.54311","volume":"9","author":"JL Elliott","year":"2020","unstructured":"Elliott JL, Eschbach JE, Koneru PC, Li W, Puray-Chavez M, Townsend D, Lawson DQ, Engelman AN, Kvaratskhelia M, Kutluay SB. Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis. Elife. 2020;9:e54311.","journal-title":"Elife"},{"key":"678_CR53","doi-asserted-by":"publisher","first-page":"e00821","DOI":"10.1128\/JVI.00821-17","volume":"91","author":"MK Madison","year":"2017","unstructured":"Madison MK, Lawson DQ, Elliott J, Ozant\u00fcrk AN, Koneru PC, Townsend D, Errando M, Kvaratskhelia M, Kutluay SB. Allosteric HIV-1 integrase inhibitors lead to premature degradation of the viral RNA genome and integrase in target cells. J Virol. 2017;91:e00821\u201317.","journal-title":"J Virol"},{"key":"678_CR54","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1128\/jvi.69.5.2729-2736.1995","volume":"69","author":"A Engelman","year":"1995","unstructured":"Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol. 1995;69:2729\u201336.","journal-title":"J Virol"},{"key":"678_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1128\/jvi.69.1.376-386.1995","volume":"69","author":"M Wiskerchen","year":"1995","unstructured":"Wiskerchen M, Muesing MA. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol. 1995;69:376\u201386.","journal-title":"J Virol"},{"key":"678_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1128\/jvi.70.2.721-728.1996","volume":"70","author":"AD Leavitt","year":"1996","unstructured":"Leavitt AD, Robles G, Alesandro N, Varmus HE. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol. 1996;70:721\u20138.","journal-title":"J Virol"},{"key":"678_CR57","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.287.5453.646","volume":"287","author":"DJ Hazuda","year":"2000","unstructured":"Hazuda DJ, Felock P, Witmer M, Wolfe A, Stillmock K, Grobler JA, Espeseth A, Gabryelski L, Schleif W, Blau C, Miller MD. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 2000;287:646\u201350.","journal-title":"Science"},{"key":"678_CR58","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1073\/pnas.93.18.9742","volume":"93","author":"CM Farnet","year":"1996","unstructured":"Farnet CM, Wang B, Lipford JR, Bushman FD. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc Natl Acad Sci U S A. 1996;93:9742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR59","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1128\/jvi.71.9.7005-7011.1997","volume":"71","author":"DJ Hazuda","year":"1997","unstructured":"Hazuda DJ, Felock PJ, Hastings JC, Pramanik B, Wolfe AL. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J Virol. 1997;71:7005\u201311.","journal-title":"J Virol"},{"key":"678_CR60","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0092-8674(90)90126-Y","volume":"62","author":"R Craigie","year":"1990","unstructured":"Craigie R, Fujiwara T, Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell. 1990;62:829\u201337.","journal-title":"Cell"},{"key":"678_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0092-8674(90)90290-U","volume":"63","author":"RA Katz","year":"1990","unstructured":"Katz RA, Merkel G, Kulkosky J, Leis J, Skalka AM. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell. 1990;63:87\u201395.","journal-title":"Cell"},{"key":"678_CR62","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1073\/pnas.200139397","volume":"97","author":"AS Espeseth","year":"2000","unstructured":"Espeseth AS, Felock P, Wolfe A, Witmer M, Grobler J, Anthony N, Egbertson M, Melamed JY, Young S, Hamill T, et al. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc Natl Acad Sci U S A. 2000;97:11244\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR63","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1073\/pnas.092056199","volume":"99","author":"JA Grobler","year":"2002","unstructured":"Grobler JA, Stillmock K, Hu B, Witmer M, Felock P, Espeseth AS, Wolfe A, Egbertson M, Bourgeois M, Melamed J, et al. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc Natl Acad Sci U S A. 2002;99:6661\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature08784","volume":"464","author":"S Hare","year":"2010","unstructured":"Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature. 2010;464:232\u20136.","journal-title":"Nature"},{"key":"678_CR65","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.1010246107","volume":"107","author":"S Hare","year":"2010","unstructured":"Hare S, Vos AM, Clayton RF, Thuring JW, Cummings MD, Cherepanov P. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc Natl Acad Sci U S A. 2010;107:20057\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR66","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.aay8015","volume":"367","author":"DO Passos","year":"2020","unstructured":"Passos DO, Li M, J\u00f3\u017awik IK, Zhao XZ, Santos-Martins D, Yang R, Smith SJ, Jeon Y, Forli S, Hughes SH, et al. Structural basis for strand-transfer inhibitor binding to HIV intasomes. Science. 2020;367:810\u20134.","journal-title":"Science"},{"key":"678_CR67","doi-asserted-by":"publisher","first-page":"eadg5953","DOI":"10.1126\/sciadv.adg5953","volume":"9","author":"M Li","year":"2023","unstructured":"Li M, Oliveira Passos D, Shan Z, Smith SJ, Sun Q, Biswas A, Choudhuri I, Strutzenberg TS, Haldane A, Deng N, et al. Mechanisms of HIV-1 integrase resistance to dolutegravir and potent inhibition of drug-resistant variants. Sci Adv. 2023;9:eadg5953.","journal-title":"Sci Adv"},{"key":"678_CR68","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1021\/bi801372d","volume":"47","author":"DR Langley","year":"2008","unstructured":"Langley DR, Samanta HK, Lin Z, Walker MA, Krystal MR, Dicker IB. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors. Biochemistry. 2008;47:13481\u20138.","journal-title":"Biochemistry"},{"key":"678_CR69","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1128\/AAC.00157-11","volume":"55","author":"KE Hightower","year":"2011","unstructured":"Hightower KE, Wang R, Deanda F, Johns BA, Weaver K, Shen Y, Tomberlin GH, Carter HL 3rd, Broderick T, Sigethy S, et al. Dolutegravir (S\/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes. Antimicrob Agents Chemother. 2011;55:4552\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"678_CR70","first-page":"e02406","volume":"65","author":"KL White","year":"2023","unstructured":"White KL, Osman N, Cuadra-Foy E, Brenner BG, Shivakumar D, Campigotto F, Tsiang M, Morganelli PA, Novikov N, Lazerwith SE, et al. Long dissociation of bictegravir from HIV-1 integrase-DNA complexes. Antimicrob Agents Chemother. 2023;65:e02406\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"678_CR71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/87979","volume":"7","author":"SL Butler","year":"2001","unstructured":"Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med. 2001;7:631\u20134.","journal-title":"Nat Med"},{"key":"678_CR72","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1128\/JVI.75.22.11253-11260.2001","volume":"75","author":"N Vandegraaff","year":"2001","unstructured":"Vandegraaff N, Kumar R, Burrell CJ, Li P. Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA. J Virol. 2001;75:11253\u201360.","journal-title":"J Virol"},{"key":"678_CR73","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1093\/jac\/dkz256","volume":"74","author":"SY Rhee","year":"2019","unstructured":"Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW. A systematic review of the genetic mechanisms of dolutegravir resistance. J Antimicrob Chemother. 2019;74:3135\u201349.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/v13020205","volume":"13","author":"SJ Smith","year":"2021","unstructured":"Smith SJ, Zhao XZ, Passos DO, Lyumkis D, Burke TR Jr., Hughes SH. Integrase strand transfer inhibitors are effective anti-HIV drugs. Viruses. 2021;13:205.","journal-title":"Viruses"},{"key":"678_CR75","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1073\/pnas.86.10.3857","volume":"86","author":"EF Terwilliger","year":"1989","unstructured":"Terwilliger EF, Godin B, Sodroski JG, Haseltine WA. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc Natl Acad Sci U S A. 1989;86:3857\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR76","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002;46:1896\u2013905.","journal-title":"Antimicrob Agents Chemother"},{"key":"678_CR77","doi-asserted-by":"publisher","first-page":"9040","DOI":"10.1073\/pnas.1820333116","volume":"116","author":"R Van Duyne","year":"2019","unstructured":"Van Duyne R, Kuo LS, Pham P, Fujii K, Freed EO. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle. Proc Natl Acad Sci U S A. 2019;116:9040\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/nar\/gkg100","volume":"31","author":"SY Rhee","year":"2003","unstructured":"Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 2003;31:298\u2013303.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"678_CR79","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1086\/505356","volume":"194","author":"RW Shafer","year":"2006","unstructured":"Shafer RW. Rationale and uses of a public HIV drug-resistance database. J Infect Dis. 2006;194(Suppl 1):S51\u201358.","journal-title":"J Infect Dis"},{"key":"678_CR80","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1056\/NEJMoa0708978","volume":"359","author":"DA Cooper","year":"2008","unstructured":"Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Kumar PN, Eron JE, et al. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med. 2008;359:355\u201365.","journal-title":"N Engl J Med"},{"key":"678_CR81","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/JVI.01534-07","volume":"82","author":"K Shimura","year":"2008","unstructured":"Shimura K, Kodama E, Sakagami Y, Matsuzaki Y, Watanabe W, Yamataka K, Watanabe Y, Ohata Y, Doi S, Sato M, et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303\/GS-9137). J Virol. 2008;82:764\u201374.","journal-title":"J Virol"},{"key":"678_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.antiviral.2009.11.004","volume":"85","author":"DJ McColl","year":"2010","unstructured":"McColl DJ, Chen X. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy. Antiviral Res. 2010;85:101\u201318.","journal-title":"Antiviral Res"},{"key":"678_CR83","doi-asserted-by":"publisher","first-page":"15910","DOI":"10.1073\/pnas.1002346107","volume":"107","author":"L Krishnan","year":"2010","unstructured":"Krishnan L, Li X, Naraharisetty HL, Hare S, Cherepanov P, Engelman A. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci U S A. 2010;107:15910\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR84","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/nar\/gkn1050","volume":"37","author":"O Delelis","year":"2009","unstructured":"Delelis O, Malet I, Na L, Tchertanov L, Calvez V, Marcelin AG, Subra F, Deprez E, Mouscadet JF. The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation. Nucleic Acids Res. 2009;37:1193\u2013201.","journal-title":"Nucleic Acids Res"},{"key":"678_CR85","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/JVI.02541-10","volume":"85","author":"Y Koh","year":"2011","unstructured":"Koh Y, Matreyek KA, Engelman A. Differential sensitivities of retroviruses to integrase strand transfer inhibitors. J Virol. 2011;85:3677\u201382.","journal-title":"J Virol"},{"key":"678_CR86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12977-018-0420-7","volume":"15","author":"SJ Smith","year":"2018","unstructured":"Smith SJ, Zhao XZ, Burke TR Jr., Hughes SH. Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants. Retrovirology. 2018;15:37.","journal-title":"Retrovirology"},{"key":"678_CR87","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.aay4919","volume":"367","author":"NJ Cook","year":"2020","unstructured":"Cook NJ, Li W, Berta D, Badaoui M, Ballandras-Colas A, Nans A, Kotecha A, Rosta E, Engelman AN, Cherepanov P. Structural basis of second-generation HIV integrase inhibitor action and viral resistance. Science. 2020;367:806\u201310.","journal-title":"Science"},{"key":"678_CR88","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/JVI.06591-11","volume":"86","author":"PK Quashie","year":"2012","unstructured":"Quashie PK, Mespl\u00e8de T, Han YS, Oliveira M, Singhroy DN, Fujiwara T, Underwood MR, Wainberg MA. Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir. J Virol. 2012;86:2696\u2013705.","journal-title":"J Virol"},{"key":"678_CR89","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3390\/v6072858","volume":"6","author":"KL White","year":"2014","unstructured":"White KL, Raffi F, Miller MD. Resistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients. Viruses. 2014;6:2858\u201379.","journal-title":"Viruses"},{"key":"678_CR90","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1128\/JVI.00495-16","volume":"90","author":"SY Rhee","year":"2016","unstructured":"Rhee SY, Sankaran K, Varghese V, Winters MA, Hurt CB, Eron JJ, Parkin N, Holmes SP, Holodniy M, Shafer RW. HIV-1 protease, reverse transcriptase, and integrase variation. J Virol. 2016;90:6058\u201370.","journal-title":"J Virol"},{"key":"678_CR91","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/jac\/dkr389","volume":"66","author":"I Malet","year":"2011","unstructured":"Malet I, Fourati S, Charpentier C, Morand-Joubert L, Armenia D, Wirden M, Sayon S, Van Houtte M, Ceccherini-Silberstein F, Brun-V\u00e9zinet F, et al. The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype. J Antimicrob Chemother. 2011;66:2827\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR92","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1093\/jac\/dkab276","volume":"76","author":"E Ndashimye","year":"2021","unstructured":"Ndashimye E, Li Y, Reyes PS, Avino M, Olabode AS, Kityo CM, Kyeyune F, Nankya I, Qui\u00f1ones-Mateu ME, Barr SD, Arts EJ. High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations. J Antimicrob Chemother. 2021;76:2965\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR93","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/S2352-3018(15)00027-2","volume":"2","author":"JM Molina","year":"2015","unstructured":"Molina JM, Clotet B, van Lunzen J, Lazzarin A, Cavassini M, Henry K, Kulagin V, Givens N, de Oliveira CF, Brennan C. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study. Lancet HIV. 2015;2:e127\u2013136.","journal-title":"Lancet HIV"},{"key":"678_CR94","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/S2352-3018(16)30011-X","volume":"3","author":"AM La Rosa","year":"2016","unstructured":"La Rosa AM, Harrison LJ, Taiwo B, Wallis CL, Zheng L, Kim P, Kumarasamy N, Hosseinipour MC, Jarocki B, Mellors JW, Collier AC. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study. Lancet HIV. 2016;3:e247\u2013258.","journal-title":"Lancet HIV"},{"key":"678_CR95","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/infdis\/jiy176","volume":"218","author":"IEA Wijting","year":"2018","unstructured":"Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver D, et al. HIV-1 resistance dynamics in patients with virologic failure to dolutegravir maintenance monotherapy. J Infect Dis. 2018;218:688\u201397.","journal-title":"J Infect Dis"},{"key":"678_CR96","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/cid\/ciy1132","volume":"69","author":"L Hocqueloux","year":"2019","unstructured":"Hocqueloux L, Raffi F, Prazuck T, Bernard L, Sunder S, Esnault JL, Rey D, Le Moal G, Roncato-Saberan M, Andr\u00e9 M, et al. Dolutegravir monotherapy versus dolutegravir\/abacavir\/lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: The randomized noninferiority MONotherapy of TiviCAY trial. Clin Infect Dis. 2019;69:1498\u2013505.","journal-title":"Clin Infect Dis"},{"key":"678_CR97","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12879-023-08288-8","volume":"23","author":"RS Diaz","year":"2023","unstructured":"Diaz RS, Hunter JR, Camargo M, Dias D, Galinskas J, Nassar I, de Lima IB, Caldeira DB, Sucupira MC, Schechter M. Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil. BMC Infect Dis. 2023;23:347.","journal-title":"BMC Infect Dis"},{"key":"678_CR98","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/v15122426","volume":"15","author":"C Henegar","year":"2023","unstructured":"Henegar C, Letang E, Wang R, Hicks C, Fox D, Jones B, de Ruiter A, Vannappagari V. A comprehensive literature review of treatment-emergent integrase resistance with dolutegravir-based regimens in real-world settings. Viruses. 2023;15:2426.","journal-title":"Viruses"},{"key":"678_CR99","doi-asserted-by":"publisher","first-page":"e00922","DOI":"10.1128\/mBio.00922-17","volume":"8","author":"I Malet","year":"2017","unstructured":"Malet I, Subra F, Charpentier C, Collin G, Descamps D, Calvez V, Marcelin AG, Delelis O. Mutations located outside the integrase gene can confer resistance to HIV-1 integrase strand transfer inhibitors. mBio. 2017;8:e00922.","journal-title":"mBio"},{"key":"678_CR100","doi-asserted-by":"publisher","first-page":"eadn0042","DOI":"10.1126\/sciadv.adn0042","volume":"10","author":"Y Hikichi","year":"2024","unstructured":"Hikichi Y, Grover JR, Sch\u00e4fer A, Mothes W, Freed EO. Epistatic pathways can drive HIV-1 escape from integrase strand transfer inhibitors. Sci Adv. 2024;10:eadn0042.","journal-title":"Sci Adv"},{"key":"678_CR101","doi-asserted-by":"publisher","first-page":"eadz8980","DOI":"10.1126\/sciadv.adz8980","volume":"11","author":"Y Hikichi","year":"2025","unstructured":"Hikichi Y, Burdick RC, Patro SC, Ding SY, Luke BT, Clark ED, Ablan SD, Wu X, Pathak VK, Freed EO. Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors. Sci Adv. 2025;11:eadz8980.","journal-title":"Sci Adv"},{"key":"678_CR102","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1093\/emboj\/17.13.3766","volume":"17","author":"PO Ilyinskii","year":"1998","unstructured":"Ilyinskii PO, Desrosiers RC. Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus. EMBO J. 1998;17:3766\u201374.","journal-title":"EMBO J"},{"key":"678_CR103","doi-asserted-by":"publisher","first-page":"13315","DOI":"10.1128\/JVI.78.23.13315-13324.2004","volume":"78","author":"JG Julias","year":"2004","unstructured":"Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH. Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage. J Virol. 2004;78:13315\u201324.","journal-title":"J Virol"},{"key":"678_CR104","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/jac\/dkz377","volume":"74","author":"I Malet","year":"2019","unstructured":"Malet I, Delelis O, Nguyen T, Leducq V, Abdi B, Morand-Joubert L, Calvez V, Marcelin AG. Variability of the HIV-1 3\u2019 polypurine tract (3\u2019PPT) region and implication in integrase inhibitor resistance. J Antimicrob Chemother. 2019;74:3440\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR105","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/ijms21051553","volume":"21","author":"A Acharya","year":"2020","unstructured":"Acharya A, Tagny CT, Mbanya D, Fonsah JY, Nchindap E, Kenmogne L, Jihyun M, Njamnshi AK, Kanmogne GD. Variability in HIV-1 integrase gene and 3\u2019-polypurine tract sequences in Cameroon clinical isolates, and implications for integrase inhibitors efficacy. Int J Mol Sci. 2020;21:1553.","journal-title":"Int J Mol Sci"},{"key":"678_CR106","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/pathogens10081027","volume":"10","author":"KK Seatla","year":"2021","unstructured":"Seatla KK, Maruapula D, Choga WT, Morerinyane O, Lockman S, Novitsky V, Kasvosve I, Moyo S, Gaseitsiwe S. Limited HIV-1 subtype C nef 3\u2019PPT variation in combination antiretroviral therapy na\u00efve and experienced people living with HIV in Botswana. Pathogens. 2021;10:1027.","journal-title":"Pathogens"},{"key":"678_CR107","first-page":"432","volume":"76","author":"S Harada","year":"1985","unstructured":"Harada S, Yamamoto N. Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line. Jpn J Cancer Res. 1985;76:432\u20135.","journal-title":"Jpn J Cancer Res"},{"key":"678_CR108","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/jac\/dkab448","volume":"77","author":"A Hachiya","year":"2022","unstructured":"Hachiya A, Kubota M, Shigemi U, Ode H, Yokomaku Y, Kirby KA, Sarafianos SG, Iwatani Y. Specific mutations in the HIV-1 G-tract of the 3\u2019-polypurine tract cause resistance to integrase strand transfer inhibitors. J Antimicrob Chemother. 2022;77:574\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR109","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/v13122501","volume":"13","author":"SJ Smith","year":"2021","unstructured":"Smith SJ, Ferris A, Zhao X, Pauly G, Schneider JP, Burke TR Jr., Hughes SH. INSTIs and NNRTIs potently inhibit HIV-1 polypurine tract mutants in a single round infection assay. Viruses. 2021;13:2501.","journal-title":"Viruses"},{"key":"678_CR110","doi-asserted-by":"publisher","first-page":"e02432","DOI":"10.1128\/AAC.02432-20","volume":"65","author":"Y Wei","year":"2021","unstructured":"Wei Y, Sluis-Cremer N. Mutations in the HIV-1 3\u2019-polypurine tract and integrase strand transfer inhibitor resistance. Antimicrob Agents Chemother. 2021;65:e02432\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"678_CR111","doi-asserted-by":"publisher","first-page":"e0036123","DOI":"10.1128\/jvi.00361-23","volume":"97","author":"JG Dekker","year":"2023","unstructured":"Dekker JG, Klaver B, Berkhout B, Das AT. HIV-1 3\u2019-polypurine tract mutations confer dolutegravir resistance by switching to an integration-independent replication mechanism via 1-LTR circles. J Virol. 2023;97:e0036123.","journal-title":"J Virol"},{"key":"678_CR112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0042-6822(83)90395-1","volume":"129","author":"SZ Salahuddin","year":"1983","unstructured":"Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC. Restricted expression of human T-cell leukemia\u2013lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 1983;129:51\u201364.","journal-title":"Virology"},{"key":"678_CR113","doi-asserted-by":"publisher","first-page":"e0102721","DOI":"10.1128\/AAC.01027-21","volume":"66","author":"JG Dekker","year":"2022","unstructured":"Dekker JG, Klaver B, Berkhout B, Das AT. Mutations in the HIV-1 3\u2019-polypurine tract can confer dolutegravir resistance. Antimicrob Agents Chemother. 2022;66:e0102721.","journal-title":"Antimicrob Agents Chemother"},{"key":"678_CR114","doi-asserted-by":"publisher","first-page":"e0067622","DOI":"10.1128\/jvi.00676-22","volume":"96","author":"C Richetta","year":"2022","unstructured":"Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, et al. Mutations in the 3\u2019-PPT lead to HIV-1 replication without integration. J Virol. 2022;96:e0067622.","journal-title":"J Virol"},{"key":"678_CR115","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1006\/viro.1995.1412","volume":"211","author":"MA Ansari-Lari","year":"1995","unstructured":"Ansari-Lari MA, Donehower LA, Gibbs RA. Analysis of human immunodeficiency virus type 1 integrase mutants. Virology. 1995;211:332\u20135.","journal-title":"Virology"},{"key":"678_CR116","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/v16121874","volume":"16","author":"X Wei","year":"2024","unstructured":"Wei X, Lipscomb JT, Tino AS, Cong ME, Ruone S, Bentz ML, Sheth M, Garcia-Lerma G, Johnson JA. HIV replication under high-level cabotegravir is associated with the appearance of 3\u2019-PPT mutations, circular DNA transcription and recombination. Viruses. 2024;16:1874.","journal-title":"Viruses"},{"key":"678_CR117","doi-asserted-by":"publisher","first-page":"9515","DOI":"10.1073\/pnas.142123199","volume":"99","author":"JG Julias","year":"2002","unstructured":"Julias JG, McWilliams MJ, Sarafianos SG, Arnold E, Hughes SH. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. Proc Natl Acad Sci U S A. 2002;99:9515\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR118","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1128\/JVI.78.7.3210-3222.2004","volume":"78","author":"ES Svarovskaia","year":"2004","unstructured":"Svarovskaia ES, Barr R, Zhang X, Pais GC, Marchand C, Pommier Y, Burke TR Jr., Pathak VK. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. J Virol. 2004;78:3210\u201322.","journal-title":"J Virol"},{"key":"678_CR119","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1128\/JVI.06386-11","volume":"86","author":"X Li","year":"2012","unstructured":"Li X, Koh Y, Engelman A. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus. J Virol. 2012;86:3861\u201379.","journal-title":"J Virol"},{"key":"678_CR120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.virol.2006.10.008","volume":"360","author":"FD Jones","year":"2007","unstructured":"Jones FD, Hughes SH. In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology. 2007;360:341\u20139.","journal-title":"Virology"},{"key":"678_CR121","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1128\/jvi.65.9.4636-4644.1991","volume":"65","author":"C Vink","year":"1991","unstructured":"Vink C, van Gent DC, Elgersma Y, Plasterk RH. Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J Virol. 1991;65:4636\u201344.","journal-title":"J Virol"},{"key":"678_CR122","doi-asserted-by":"publisher","first-page":"e00006","DOI":"10.1128\/mBio.00006-18","volume":"9","author":"AT Das","year":"2018","unstructured":"Das AT, Berkhout B. How polypurine tract changes in the HIV-1 RNA genome can cause resistance against the integrase inhibitor dolutegravir. mBio. 2018;9:e00006\u201318.","journal-title":"mBio"},{"key":"678_CR123","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/nar\/gkl909","volume":"35","author":"JW Rausch","year":"2007","unstructured":"Rausch JW, Le Grice SF. Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res. 2007;35:256\u201368.","journal-title":"Nucleic Acids Res"},{"key":"678_CR124","doi-asserted-by":"publisher","first-page":"e0122953","DOI":"10.1371\/journal.pone.0122953","volume":"10","author":"JW Rausch","year":"2015","unstructured":"Rausch JW, Tian M, Li Y, Angelova L, Bagaya BS, Krebs KC, Qian F, Zhu C, Arts EJ, Le Grice SF, Gao Y. SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness. PLoS ONE. 2015;10:e0122953.","journal-title":"PLoS ONE"},{"key":"678_CR125","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/360358a0","volume":"360","author":"S Hallenberger","year":"1992","unstructured":"Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 1992;360:358\u201361.","journal-title":"Nature"},{"key":"678_CR126","doi-asserted-by":"publisher","first-page":"37412","DOI":"10.31083\/FBL37412","volume":"30","author":"A Elalouf","year":"2025","unstructured":"Elalouf A, Elalouf H, Maoz H. HIV-1 entry mechanisms: Protein-host receptor interactions and membrane fusion dynamics. Front Biosci (Landmark Ed). 2025;30:37412.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"678_CR127","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41579-025-01206-6","volume":"23","author":"PJ Klasse","year":"2025","unstructured":"Klasse PJ, Sanders RW, Ward AB, Wilson IA, Moore JP. The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies. Nat Rev Microbiol. 2025;23:734\u201352.","journal-title":"Nat Rev Microbiol"},{"key":"678_CR128","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/312763a0","volume":"312","author":"AG Dalgleish","year":"1984","unstructured":"Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763\u20137.","journal-title":"Nature"},{"key":"678_CR129","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/312767a0","volume":"312","author":"D Klatzmann","year":"1984","unstructured":"Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984;312:767\u20138.","journal-title":"Nature"},{"key":"678_CR130","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","volume":"272","author":"G Alkhatib","year":"1996","unstructured":"Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955\u20138.","journal-title":"Science"},{"key":"678_CR131","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","volume":"85","author":"H Choe","year":"1996","unstructured":"Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135\u201348.","journal-title":"Cell"},{"key":"678_CR132","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/381661a0","volume":"381","author":"H Deng","year":"1996","unstructured":"Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661\u20136.","journal-title":"Nature"},{"key":"678_CR133","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/381667a0","volume":"381","author":"T Dragic","year":"1996","unstructured":"Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. HIV-1 entry into CD4+\u2009cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667\u201373.","journal-title":"Nature"},{"key":"678_CR134","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/384179a0","volume":"384","author":"L Wu","year":"1996","unstructured":"Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 1996;384:179\u201383.","journal-title":"Nature"},{"key":"678_CR135","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nsb1295-1075","volume":"2","author":"M Lu","year":"1995","unstructured":"Lu M, Blacklow SC, Kim PS. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol. 1995;2:1075\u201382.","journal-title":"Nat Struct Biol"},{"key":"678_CR136","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","volume":"89","author":"DC Chan","year":"1997","unstructured":"Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997;89:263\u201373.","journal-title":"Cell"},{"key":"678_CR137","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/387426a0","volume":"387","author":"W Weissenhorn","year":"1997","unstructured":"Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 1997;387:426\u201330.","journal-title":"Nature"},{"key":"678_CR138","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1126\/science.1254426","volume":"346","author":"JB Munro","year":"2014","unstructured":"Munro JB, Gorman J, Ma X, Zhou Z, Arthos J, Burton DR, Koff WC, Courter JR, Smith AB 3rd, Kwong PD, et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science. 2014;346:759\u201363.","journal-title":"Science"},{"key":"678_CR139","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41467-017-01119-w","volume":"8","author":"A Herschhorn","year":"2017","unstructured":"Herschhorn A, Gu C, Moraca F, Ma X, Farrell M, Smith AB 3rd, Pancera M, Kwong PD, Sch\u00f6n A, Freire E, et al. The \u03b220-\u03b221 of gp120 is a regulatory switch for HIV-1 Env conformational transitions. Nat Commun. 2017;8:1049.","journal-title":"Nat Commun"},{"key":"678_CR140","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0092-8674(86)90778-6","volume":"45","author":"BR Starcich","year":"1986","unstructured":"Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III\/LAV, the retrovirus of AIDS. Cell. 1986;45:637\u201348.","journal-title":"Cell"},{"key":"678_CR141","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/aid.1989.5.431","volume":"5","author":"WR Gallaher","year":"1989","unstructured":"Gallaher WR, Ball JM, Garry RF, Griffin MC, Montelaro RC. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses. 1989;5:431\u201340.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"678_CR142","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/0042-6822(92)90038-Q","volume":"186","author":"H Sato","year":"1992","unstructured":"Sato H, Orenstein J, Dimitrov D, Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 1992;186:712\u201324.","journal-title":"Virology"},{"key":"678_CR143","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1128\/jvi.67.4.2182-2190.1993","volume":"67","author":"DS Dimitrov","year":"1993","unstructured":"Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol. 1993;67:2182\u201390.","journal-title":"J Virol"},{"key":"678_CR144","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1084\/jem.20030648","volume":"199","author":"C Jolly","year":"2004","unstructured":"Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med. 2004;199:283\u201393.","journal-title":"J Exp Med"},{"key":"678_CR145","doi-asserted-by":"publisher","first-page":"12582","DOI":"10.1128\/JVI.00381-07","volume":"81","author":"P Chen","year":"2007","unstructured":"Chen P, H\u00fcbner W, Spinelli MA, Chen BK. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007;81:12582\u201395.","journal-title":"J Virol"},{"key":"678_CR146","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.1128\/JVI.00231-11","volume":"85","author":"A Del Portillo","year":"2011","unstructured":"Del Portillo A, Tripodi J, Najfeld V, Wodarz D, Levy DN, Chen BK. Multiploid inheritance of HIV-1 during cell-to-cell infection. J Virol. 2011;85:7169\u201376.","journal-title":"J Virol"},{"key":"678_CR147","doi-asserted-by":"publisher","first-page":"14566","DOI":"10.1073\/pnas.97.26.14566","volume":"97","author":"S Gratton","year":"2000","unstructured":"Gratton S, Cheynier R, Dumaurier MJ, Oksenhendler E, Wain-Hobson S. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci U S A. 2000;97:14566\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR148","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/418144a","volume":"418","author":"A Jung","year":"2002","unstructured":"Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, Meese E, Wain-Hobson S, Meyerhans A. Recombination: Multiply infected spleen cells in HIV patients. Nature. 2002;418:144.","journal-title":"Nature"},{"key":"678_CR149","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1073\/pnas.1107729108","volume":"108","author":"L Josefsson","year":"2011","unstructured":"Josefsson L, King MS, Makitalo B, Br\u00e4nnstr\u00f6m J, Shao W, Maldarelli F, Kearney MF, Hu WS, Chen J, Gaines H, et al. Majority of CD4+\u2009T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A. 2011;108:11199\u2013204.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR150","doi-asserted-by":"publisher","first-page":"e1003432","DOI":"10.1371\/journal.ppat.1003432","volume":"9","author":"L Josefsson","year":"2013","unstructured":"Josefsson L, Palmer S, Faria NR, Lemey P, Casazza J, Ambrozak D, Kearney M, Shao W, Kottilil S, Sneller M, et al. Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+\u2009T-cells contain one HIV-1 DNA molecule. PLoS Pathog. 2013;9:e1003432.","journal-title":"PLoS Pathog"},{"key":"678_CR151","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1128\/JVI.79.4.2493-2505.2005","volume":"79","author":"R Lu","year":"2005","unstructured":"Lu R, Lim\u00f3n A, Ghory HZ, Engelman A. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J Virol. 2005;79:2493\u2013505.","journal-title":"J Virol"},{"key":"678_CR152","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature10347","volume":"477","author":"A Sigal","year":"2011","unstructured":"Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 2011;477:95\u20138.","journal-title":"Nature"},{"key":"678_CR153","doi-asserted-by":"publisher","first-page":"e53138","DOI":"10.1371\/journal.pone.0053138","volume":"8","author":"P Zhong","year":"2013","unstructured":"Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W. Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. PLoS ONE. 2013;8:e53138.","journal-title":"PLoS ONE"},{"key":"678_CR154","doi-asserted-by":"publisher","first-page":"e1003982","DOI":"10.1371\/journal.ppat.1003982","volume":"10","author":"LM Agosto","year":"2014","unstructured":"Agosto LM, Zhong P, Munro J, Mothes W. Highly active antiretroviral therapies are effective against HIV-1 cell-to-cell transmission. PLoS Pathog. 2014;10:e1003982.","journal-title":"PLoS Pathog"},{"key":"678_CR155","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/aid.1995.11.323","volume":"11","author":"C Wild","year":"1995","unstructured":"Wild C, Greenwell T, Shugars D, Rimsky-Clarke L, Matthews T. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res Hum Retroviruses. 1995;11:323\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"678_CR156","doi-asserted-by":"publisher","first-page":"11013","DOI":"10.1073\/pnas.1832214100","volume":"100","author":"PF Lin","year":"2003","unstructured":"Lin PF, Blair W, Wang T, Spicer T, Guo Q, Zhou N, Gong YF, Wang HG, Rose R, Yamanaka G, et al. A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc Natl Acad Sci U S A. 2003;100:11013\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR157","doi-asserted-by":"publisher","first-page":"e03134","DOI":"10.1128\/mBio.03134-20","volume":"12","author":"Y Hikichi","year":"2021","unstructured":"Hikichi Y, Van Duyne R, Pham P, Groebner JL, Wiegand A, Mellors JW, Kearney MF, Freed EO. Mechanistic analysis of the broad antiretroviral resistance conferred by HIV-1 envelope glycoprotein mutations. mBio. 2021;12:e03134\u201320.","journal-title":"mBio"},{"key":"678_CR158","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1128\/JVI.02651-09","volume":"84","author":"N Martin","year":"2010","unstructured":"Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol. 2010;84:3516\u201327.","journal-title":"J Virol"},{"key":"678_CR159","doi-asserted-by":"publisher","first-page":"e1002634","DOI":"10.1371\/journal.ppat.1002634","volume":"8","author":"IA Abela","year":"2012","unstructured":"Abela IA, Berlinger L, Schanz M, Reynell L, G\u00fcnthard HF, Rusert P, Trkola A. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog. 2012;8:e1002634.","journal-title":"PLoS Pathog"},{"key":"678_CR160","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1128\/jvi.65.4.2119-2123.1991","volume":"65","author":"E Helseth","year":"1991","unstructured":"Helseth E, Olshevsky U, Furman C, Sodroski J. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J Virol. 1991;65:2119\u201323.","journal-title":"J Virol"},{"key":"678_CR161","doi-asserted-by":"publisher","first-page":"02219","DOI":"10.1128\/JVI.02219-16","volume":"91","author":"B Pacheco","year":"2017","unstructured":"Pacheco B, Alsahafi N, Debbeche O, Pr\u00e9vost J, Ding S, Chapleau JP, Herschhorn A, Madani N, Princiotto A, Melillo B, et al. Residues in the gp41 ectodomain regulate HIV-1 envelope glycoprotein conformational transitions induced by gp120-directed inhibitors. J Virol. 2017;91:02219\u201316.","journal-title":"J Virol"},{"key":"678_CR162","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0042-6822(03)00273-3","volume":"313","author":"X Yang","year":"2003","unstructured":"Yang X, Mahony E, Holm GH, Kassa A, Sodroski J. Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits. Virology. 2003;313:117\u201325.","journal-title":"Virology"},{"key":"678_CR163","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.molcel.2010.02.012","volume":"37","author":"A Finzi","year":"2010","unstructured":"Finzi A, Xiang SH, Pacheco B, Wang L, Haight J, Kassa A, Danek B, Pancera M, Kwong PD, Sodroski J. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Mol Cell. 2010;37:656\u201367.","journal-title":"Mol Cell"},{"issue":"Pt 11","key":"678_CR164","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1099\/0022-1317-67-11-2533","volume":"67","author":"J Schneider","year":"1986","unstructured":"Schneider J, Kaaden O, Copeland TD, Oroszlan S, Hunsmann G. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol. 1986;67(Pt 11):2533\u20138.","journal-title":"J Gen Virol"},{"key":"678_CR165","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.2251501","volume":"250","author":"JP Moore","year":"1990","unstructured":"Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science. 1990;250:1139\u201342.","journal-title":"Science"},{"key":"678_CR166","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nature13601","volume":"515","author":"J Huang","year":"2014","unstructured":"Huang J, Kang BH, Pancera M, Lee JH, Tong T, Feng Y, Imamichi H, Georgiev IS, Chuang GY, Druz A, et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature. 2014;515:138\u201342.","journal-title":"Nature"},{"key":"678_CR167","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1073\/pnas.91.20.9564","volume":"91","author":"JK Yee","year":"1994","unstructured":"Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A. 1994;91:9564\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR168","doi-asserted-by":"publisher","first-page":"14747","DOI":"10.1073\/pnas.1305066110","volume":"110","author":"J Varadarajan","year":"2013","unstructured":"Varadarajan J, McWilliams MJ, Hughes SH. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Proc Natl Acad Sci U S A. 2013;110:14747\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR169","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1128\/JVI.74.7.3046-3057.2000","volume":"74","author":"A Cimarelli","year":"2000","unstructured":"Cimarelli A, Sandin S, H\u00f6glund S, Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol. 2000;74:3046\u201357.","journal-title":"J Virol"},{"key":"678_CR170","doi-asserted-by":"publisher","first-page":"e02319","DOI":"10.1128\/JVI.02319-16","volume":"91","author":"KA Dilley","year":"2017","unstructured":"Dilley KA, Nikolaitchik OA, Galli A, Burdick RC, Levine L, Li K, Rein A, Pathak VK, Hu WS. Interactions between HIV-1 Gag and viral RNA genome enhance virion assembly. J Virol. 2017;91:e02319\u201316.","journal-title":"J Virol"},{"key":"678_CR171","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/rna.7.6.14115","volume":"7","author":"JG Levin","year":"2010","unstructured":"Levin JG, Mitra M, Mascarenhas A, Musier-Forsyth K. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 2010;7:754\u201374.","journal-title":"RNA Biol"},{"key":"678_CR172","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1093\/nar\/gkab236","volume":"49","author":"K Jiang","year":"2021","unstructured":"Jiang K, Humbert N, Rouzina KKS, Mely I, Westerlund Y. The HIV-1 nucleocapsid chaperone protein forms locally compacted globules on long double-stranded DNA. Nucleic Acids Res. 2021;49:4550\u201363.","journal-title":"Nucleic Acids Res"},{"key":"678_CR173","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/v14020235","volume":"14","author":"H Gien","year":"2022","unstructured":"Gien H, Morse M, McCauley MJ, Kitzrow JP, Musier-Forsyth K, Gorelick RJ, Rouzina I, Williams MC. HIV-1 nucleocapsid protein binds double-stranded DNA in multiple modes to regulate compaction and capsid uncoating. Viruses. 2022;14:235.","journal-title":"Viruses"},{"key":"678_CR174","doi-asserted-by":"publisher","first-page":"e00289","DOI":"10.1128\/JVI.00289-17","volume":"91","author":"S Rankovic","year":"2017","unstructured":"Rankovic S, Varadarajan J, Ramalho R, Aiken C, Rousso I. Reverse transcription mechanically initiates HIV-1 capsid disassembly. J Virol. 2017;91:e00289\u201317.","journal-title":"J Virol"},{"key":"678_CR175","doi-asserted-by":"publisher","first-page":"eabc8420","DOI":"10.1126\/science.abc8420","volume":"370","author":"DE Christensen","year":"2020","unstructured":"Christensen DE, Ganser-Pornillos BK, Johnson JS, Pornillos O, Sundquist WI. Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science. 2020;370:eabc8420.","journal-title":"Science"},{"key":"678_CR176","doi-asserted-by":"publisher","first-page":"e00166","DOI":"10.1128\/JVI.00166-21","volume":"95","author":"S Rankovic","year":"2021","unstructured":"Rankovic S, Deshpande A, Harel S, Aiken C, Rousso I. HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription. J Virol. 2021;95:e00166\u201321.","journal-title":"J Virol"},{"key":"678_CR177","doi-asserted-by":"publisher","first-page":"eadn7033","DOI":"10.1126\/sciadv.adn7033","volume":"10","author":"RC Burdick","year":"2024","unstructured":"Burdick RC, Morse M, Rouzina I, Williams MC, Hu WS, Pathak VK. HIV-1 uncoating requires long double-stranded reverse transcription products. Sci Adv. 2024;10:eadn7033.","journal-title":"Sci Adv"},{"key":"678_CR178","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1128\/jvi.71.8.6225-6229.1997","volume":"71","author":"S Carteau","year":"1997","unstructured":"Carteau S, Batson SC, Poljak L, Mouscadet JF, de Rocquigny H, Darlix JL, Roques BP, K\u00e4s E, Auclair C. Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J Virol. 1997;71:6225\u20139.","journal-title":"J Virol"},{"key":"678_CR179","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1128\/JVI.73.8.6670-6679.1999","volume":"73","author":"S Carteau","year":"1999","unstructured":"Carteau S, Gorelick RJ, Bushman FD. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J Virol. 1999;73:6670\u20139.","journal-title":"J Virol"},{"key":"678_CR180","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1128\/JVI.77.2.1598-1603.2003","volume":"77","author":"K Gao","year":"2003","unstructured":"Gao K, Gorelick RJ, Johnson DG, Bushman F. Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro. J Virol. 2003;77:1598\u2013603.","journal-title":"J Virol"},{"key":"678_CR181","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0022-2836(03)00472-8","volume":"329","author":"L Poljak","year":"2003","unstructured":"Poljak L, Batson SM, Ficheux D, Roques BP, Darlix JL, K\u00e4s E. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins. J Mol Biol. 2003;329:411\u201321.","journal-title":"J Mol Biol"},{"key":"678_CR182","doi-asserted-by":"publisher","first-page":"29334","DOI":"10.1074\/jbc.M505367200","volume":"280","author":"M Li","year":"2005","unstructured":"Li M, Craigie R. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J Biol Chem. 2005;280:29334\u20139.","journal-title":"J Biol Chem"},{"key":"678_CR183","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/viro.1999.9629","volume":"256","author":"RJ Gorelick","year":"1999","unstructured":"Gorelick RJ, Gagliardi TD, Bosche WJ, Wiltrout TA, Coren LV, Chabot DJ, Lifson JD, Henderson LE, Arthur LO. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology. 1999;256:92\u2013104.","journal-title":"Virology"},{"key":"678_CR184","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1128\/JVI.74.9.4273-4283.2000","volume":"74","author":"A Cimarelli","year":"2000","unstructured":"Cimarelli A, Sandin S, H\u00f6glund S, Luban J. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. J Virol. 2000;74:4273\u201383.","journal-title":"J Virol"},{"key":"678_CR185","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1128\/JVI.77.2.1469-1480.2003","volume":"77","author":"JS Buckman","year":"2003","unstructured":"Buckman JS, Bosche WJ, Gorelick RJ. Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J Virol. 2003;77:1469\u201380.","journal-title":"J Virol"},{"key":"678_CR186","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.virol.2006.05.014","volume":"353","author":"JA Thomas","year":"2006","unstructured":"Thomas JA, Gagliardi TD, Alvord WG, Lubomirski M, Bosche WJ, Gorelick RJ. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology. 2006;353:41\u201351.","journal-title":"Virology"},{"key":"678_CR187","doi-asserted-by":"publisher","first-page":"107520","DOI":"10.1016\/j.celrep.2020.03.084","volume":"31","author":"A Monette","year":"2020","unstructured":"Monette A, Niu M, Chen L, Rao S, Gorelick RJ, Mouland AJ. Pan-retroviral nucleocapsid-mediated phase separation regulates genomic RNA positioning and trafficking. Cell Rep. 2020;31:107520.","journal-title":"Cell Rep"},{"key":"678_CR188","doi-asserted-by":"publisher","first-page":"35681","DOI":"10.1074\/jbc.M109.036616","volume":"284","author":"E Michailidis","year":"2009","unstructured":"Michailidis E, Marchand B, Kodama EN, Singh K, Matsuoka M, Kirby KA, Ryan EM, Sawani AM, Nagy E, Ashida N, et al. Mechanism of inhibition of HIV-1 reverse transcriptase by 4\u2019-Ethynyl-2-fluoro-2\u2019-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem. 2009;284:35681\u201391.","journal-title":"J Biol Chem"},{"key":"678_CR189","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12864-020-6647-4","volume":"21","author":"DW Wells","year":"2020","unstructured":"Wells DW, Guo S, Shao W, Bale MJ, Coffin JM, Hughes SH, Wu X. An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses. BMC Genomics. 2020;21:216.","journal-title":"BMC Genomics"},{"key":"678_CR190","doi-asserted-by":"publisher","first-page":"e83605","DOI":"10.7554\/eLife.83605","volume":"13","author":"KMR Faysal","year":"2024","unstructured":"Faysal KMR, Walsh JC, Renner N, M\u00e1rquez CL, Shah VB, Tuckwell AJ, Christie MP, Parker MW, Turville SG, Towers GJ, et al. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure. Elife. 2024;13:e83605.","journal-title":"Elife"},{"key":"678_CR191","doi-asserted-by":"publisher","first-page":"e2420497122","DOI":"10.1073\/pnas.2420497122","volume":"122","author":"C Li","year":"2025","unstructured":"Li C, Burdick RC, Siddiqui R, Janaka SK, Hsia RC, Hu WS, Pathak VK. Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice. Proc Natl Acad Sci U S A. 2025;122:e2420497122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"678_CR192","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1093\/emboj\/16.24.7511","volume":"16","author":"SQ Wei","year":"1997","unstructured":"Wei SQ, Mizuuchi K, Craigie R. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J. 1997;16:7511\u201320.","journal-title":"EMBO J"},{"key":"678_CR193","doi-asserted-by":"publisher","first-page":"17358","DOI":"10.1074\/jbc.274.24.17358","volume":"274","author":"H Chen","year":"1999","unstructured":"Chen H, Wei SQ, Engelman A. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome. J Biol Chem. 1999;274:17358\u201364.","journal-title":"J Biol Chem"},{"key":"678_CR194","doi-asserted-by":"publisher","first-page":"e105078","DOI":"10.1371\/journal.pone.0105078","volume":"9","author":"M Li","year":"2014","unstructured":"Li M, Jurado KA, Lin S, Engelman A, Craigie R. Engineered hyperactive integrase for concerted HIV-1 DNA integration. PLoS ONE. 2014;9:e105078.","journal-title":"PLoS ONE"},{"key":"678_CR195","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.aah5163","volume":"355","author":"DO Passos","year":"2017","unstructured":"Passos DO, Li M, Yang R, Rebensburg SV, Ghirlando R, Jeon Y, Shkriabai N, Kvaratskhelia M, Craigie R, Lyumkis D. Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome. Science. 2017;355:89\u201392.","journal-title":"Science"},{"key":"678_CR196","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.jmb.2020.01.040","volume":"432","author":"M Li","year":"2020","unstructured":"Li M, Chen X, Wang H, Jurado KA, Engelman AN, Craigie R. A peptide derived from lens epithelium-derived growth factor stimulates HIV-1 DNA integration and facilitates intasome structural studies. J Mol Biol. 2020;432:2055\u201366.","journal-title":"J Mol Biol"},{"key":"678_CR197","doi-asserted-by":"publisher","first-page":"168557","DOI":"10.1016\/j.jmb.2024.168557","volume":"436","author":"M Li","year":"2024","unstructured":"Li M, Yang R, Chen X, Wang H, Ghirlando R, Dimitriadis EK, Craigie R. HIV-1 integrase assembles multiple species of stable synaptic complex intasomes that are active for concerted DNA integration in vitro. J Mol Biol. 2024;436:168557.","journal-title":"J Mol Biol"},{"key":"678_CR198","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/v16071166","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, Li Z, Chen X, Cui Y, Engelman AN, Craigie R. HIV-1 intasomes assembled with excess integrase C-terminal domain protein facilitate structural studies by Cryo-EM and reveal the role of the integrase C-terminal tail in HIV-1 integration. Viruses. 2024;16:1166.","journal-title":"Viruses"},{"key":"678_CR199","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/infdis\/jiu051","volume":"210","author":"A Castagna","year":"2014","unstructured":"Castagna A, Maggiolo F, Penco G, Wright D, Mills A, Grossberg R, Molina JM, Chas J, Durant J, Moreno S, et al. Dolutegravir in antiretroviral-experienced patients with raltegravir- and\/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study. J Infect Dis. 2014;210:354\u201362.","journal-title":"J Infect Dis"},{"key":"678_CR200","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/aid.2013.0210","volume":"30","author":"LR Galetto","year":"2014","unstructured":"Galetto LR, Lunge VR, B\u00e9ria JU, Tietzmann DC, Stein AT, Simon D. Short communication: Prevalence and risk factors for human T cell lymphotropic virus infection in Southern Brazilian HIV-positive patients. AIDS Res Hum Retroviruses. 2014;30:907\u201311.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"678_CR201","doi-asserted-by":"publisher","first-page":"572381","DOI":"10.3389\/fmicb.2020.572381","volume":"11","author":"SP Alencar","year":"2020","unstructured":"Alencar SP, Souza MC, Fonseca RRS, Menezes CR, Azevedo VN, Ribeiro ALR, Lima SS, Laurentino RV, Barbosa M, Freitas FB, et al. Prevalence and molecular epidemiology of human T-lymphotropic virus (HTLV) infection in people living with HIV\/AIDS in the Par\u00e1 State, Amazon Region of Brazil. Front Microbiol. 2020;11:572381.","journal-title":"Front Microbiol"},{"key":"678_CR202","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1001\/jama.1986.03380170081023","volume":"256","author":"S Gartner","year":"1986","unstructured":"Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M. Virus isolation from and identification of HTLV-III\/LAV-producing cells in brain tissue from a patient with AIDS. JAMA. 1986;256:2365\u201371.","journal-title":"JAMA"},{"key":"678_CR203","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fmicb.2012.00222","volume":"3","author":"H Hoshino","year":"2012","unstructured":"Hoshino H. Cellular factors involved in HTLV-1 entry and pathogenicit. Front Microbiol. 2012;3:222.","journal-title":"Front Microbiol"},{"key":"678_CR204","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F Barr\u00e9-Sinoussi","year":"1983","unstructured":"Barr\u00e9-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, V\u00e9zinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868\u201371.","journal-title":"Science"},{"key":"678_CR205","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12274","volume":"498","author":"A Cooper","year":"2013","unstructured":"Cooper A, Garc\u00eda M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature. 2013;498:376\u20139.","journal-title":"Nature"},{"key":"678_CR206","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","volume":"12","author":"NL Galloway","year":"2015","unstructured":"Galloway NL, Doitsh G, Monroe KM, Yang Z, Mu\u00f1oz-Arias I, Levy DN, Greene WC. Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells. Cell Rep. 2015;12:1555\u201363.","journal-title":"Cell Rep"},{"key":"678_CR207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/infdis\/jiaf500","volume":"233","author":"C Kelly","year":"2026","unstructured":"Kelly C, Lester JS, Bradshaw D, Bibby DF, Mohamed H, Murphy G, Brown A, Sabin C, Geretti AM, Mbisa JL. Real-world prevalence of nonintegrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the United Kingdom. J Infect Dis. 2026;233:49\u201358.","journal-title":"J Infect Dis"},{"key":"678_CR208","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/clinchem\/hvad108","volume":"69","author":"TT Ng","year":"2023","unstructured":"Ng TT, Su J, Lao HY, Lui WW, Chan CT, Leung AW, Jim SH, Lee LK, Shehzad S, Tam KK, et al. Long-read sequencing with hierarchical clustering for antiretroviral resistance profiling of mixed human immunodeficiency virus quasispecies. Clin Chem. 2023;69:1174\u201385.","journal-title":"Clin Chem"},{"key":"678_CR209","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1093\/nar\/gkab231","volume":"49","author":"CM Gallardo","year":"2021","unstructured":"Gallardo CM, Wang S, Montiel-Garcia DJ, Little SJ, Smith DM, Routh AL, Torbett BE. MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution. Nucleic Acids Res. 2021;49:e70.","journal-title":"Nucleic Acids Res"},{"key":"678_CR210","doi-asserted-by":"publisher","first-page":"105939","DOI":"10.1016\/j.jcv.2026.105939","volume":"184","author":"C Vellas","year":"2026","unstructured":"Vellas C, Poiteau L, Raymond S, Carcenac R, Ranger N, Demmou S, Mohammed S, Delobel P, Izopet J. HIV-1 gag genotypic resistance testing using short-read and long-read next-generation sequencing technologies. J Clin Virol. 2026;184:105939.","journal-title":"J Clin Virol"},{"key":"678_CR211","doi-asserted-by":"publisher","first-page":"e25024","DOI":"10.1002\/jia2.25024","volume":"20","author":"M Coetzer","year":"2017","unstructured":"Coetzer M, Ledingham L, Diero L, Kemboi E, Orido M, Kantor R. Gp41 and Gag amino acids linked to HIV-1 protease inhibitor-based second-line failure in HIV-1 subtype A from Western Kenya. J Int AIDS Soc. 2017;20:e25024.","journal-title":"J Int AIDS Soc"},{"key":"678_CR212","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/jac\/dkz151","volume":"74","author":"L Castain","year":"2019","unstructured":"Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, et al. New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations. J Antimicrob Chemother. 2019;74:2019\u201323.","journal-title":"J Antimicrob Chemother"},{"key":"678_CR213","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","volume":"165","author":"GB Stewart-Jones","year":"2016","unstructured":"Stewart-Jones GB, Soto C, Lemmin T, Chuang GY, Druz A, Kong R, Thomas PV, Wagh K, Zhou T, Behrens AJ, et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G. Cell. 2016;165:813\u201326.","journal-title":"Cell"},{"key":"678_CR214","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/viro.1996.0266","volume":"219","author":"KA Barrie","year":"1996","unstructured":"Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag\/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Virology. 1996;219:407\u201316.","journal-title":"Virology"},{"key":"678_CR215","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1126\/science.279.5349.384","volume":"279","author":"RN De Guzman","year":"1998","unstructured":"De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science. 1998;279:384\u20138.","journal-title":"Science"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-026-00678-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-026-00678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-026-00678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:01:56Z","timestamp":1783976516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12977-026-00678-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":215,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s12977-026-00678-5","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; all materials are original.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}